Delta Insurance Company (EGX:DEIN)
11.38
0.00 (0.00%)
At close: Aug 7, 2025
Marinus Pharmaceuticals Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
Investments in Debt Securities | 3,790 | 2,825 | 2,548 | 2,424 | 2,219 | 1,861 | Upgrade |
Investments in Equity & Preferred Securities | 11.65 | 10.54 | 8.58 | 7.67 | 6.33 | 4.33 | Upgrade |
Policy Loans | 5.48 | 5.44 | 4.82 | 5.42 | 6.06 | 6.67 | Upgrade |
Other Investments | 7.08 | 6.72 | 5.78 | 81.27 | 53.73 | 34.78 | Upgrade |
Total Investments | 4,057 | 3,059 | 2,792 | 2,577 | 2,294 | 1,919 | Upgrade |
Cash & Equivalents | 984.7 | 1,498 | 780.32 | 303.78 | 201.42 | 239.88 | Upgrade |
Reinsurance Recoverable | 98.2 | 103.2 | 50.69 | 34.65 | 23.32 | 32.52 | Upgrade |
Other Receivables | 439.36 | 321.54 | 285.36 | 259.03 | 193.56 | 149.39 | Upgrade |
Property, Plant & Equipment | 35.92 | 27.19 | 27.91 | 27.63 | 28.02 | 23.95 | Upgrade |
Other Intangible Assets | 1.33 | 1.45 | 1.93 | 0.53 | 0.71 | 0.41 | Upgrade |
Restricted Cash | 4.91 | 4.96 | 5.94 | 7.2 | 4.23 | 0.88 | Upgrade |
Other Current Assets | 10.34 | 15.62 | 11.7 | 8.2 | 5.42 | 9.46 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | 1.29 | - | - | Upgrade |
Other Long-Term Assets | 52.88 | 46.17 | 21.98 | 2.63 | 30.05 | 32.07 | Upgrade |
Total Assets | 5,685 | 5,077 | 3,978 | 3,222 | 2,781 | 2,408 | Upgrade |
Accounts Payable | - | - | - | 155.58 | - | - | Upgrade |
Accrued Expenses | 209.88 | 134.87 | 95.45 | - | 29.73 | 15.23 | Upgrade |
Insurance & Annuity Liabilities | 2,979 | 2,759 | 2,314 | 1,852 | 1,703 | 1,591 | Upgrade |
Unpaid Claims | 46.71 | 46.02 | 25.05 | 25.41 | 35.96 | 40.46 | Upgrade |
Unearned Premiums | 0.02 | 0.02 | 0.36 | - | 0.12 | 0.43 | Upgrade |
Reinsurance Payable | 162.6 | 109.8 | 103.66 | 101.14 | 68.65 | 50.98 | Upgrade |
Current Income Taxes Payable | 70.85 | 53.32 | 33.23 | - | 19.75 | 10.73 | Upgrade |
Long-Term Deferred Tax Liabilities | 9.78 | 9.58 | 2.85 | 2.96 | 13.86 | 13.84 | Upgrade |
Separate Account Liability | 206.94 | 189.07 | 128.75 | 81.27 | 53.73 | 34.78 | Upgrade |
Other Current Liabilities | 315.48 | 21.63 | 16.41 | - | 12.84 | 14.26 | Upgrade |
Other Long-Term Liabilities | 34.03 | 50.23 | 30.9 | 7.98 | 28.01 | 15.81 | Upgrade |
Total Liabilities | 4,035 | 3,374 | 2,751 | 2,226 | 1,966 | 1,787 | Upgrade |
Common Stock | 400 | 400 | 350 | 350 | 126 | 126 | Upgrade |
Retained Earnings | 1,144 | 1,198 | 769.2 | 588.62 | 575.08 | 419.53 | Upgrade |
Comprehensive Income & Other | 104.99 | 104.62 | 107.43 | 56.86 | 113.34 | 74.56 | Upgrade |
Total Common Equity | 1,649 | 1,703 | 1,227 | 995.48 | 814.42 | 620.09 | Upgrade |
Minority Interest | 0.91 | 0.88 | 0.58 | 0.4 | 0.3 | 0.22 | Upgrade |
Shareholders' Equity | 1,650 | 1,704 | 1,227 | 995.88 | 814.72 | 620.31 | Upgrade |
Total Liabilities & Equity | 5,685 | 5,077 | 3,978 | 3,222 | 2,781 | 2,408 | Upgrade |
Filing Date Shares Outstanding | 125 | 125 | 125 | 125 | 125 | 125 | Upgrade |
Total Common Shares Outstanding | 125 | 125 | 125 | 125 | 125 | 125 | Upgrade |
Net Cash (Debt) | 984.7 | 1,498 | 780.32 | 303.78 | 201.42 | 239.88 | Upgrade |
Net Cash Growth | 273.44% | 91.94% | 156.88% | 50.82% | -16.03% | 28.92% | Upgrade |
Net Cash Per Share | 7.88 | 11.98 | 6.24 | 2.43 | 1.61 | 1.92 | Upgrade |
Book Value Per Share | 13.19 | 13.62 | 9.81 | 7.96 | 6.52 | 4.96 | Upgrade |
Tangible Book Value | 1,648 | 1,701 | 1,225 | 994.95 | 813.71 | 619.67 | Upgrade |
Tangible Book Value Per Share | 13.18 | 13.61 | 9.80 | 7.96 | 6.51 | 4.96 | Upgrade |
Machinery | - | 50.86 | 48.42 | 44.64 | 42.27 | 39.24 | Upgrade |
Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.